BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11365288)

  • 21. Naltrexone implants compared to methadone: outcomes six months after prison release.
    Lobmaier PP; Kunøe N; Gossop M; Katevoll T; Waal H
    Eur Addict Res; 2010; 16(3):139-45. PubMed ID: 20424458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid substitution therapy for people living in German prisons-inequality compared with civic sector.
    Stöver H; Jamin D; Michels II; Knorr B; Keppler K; Deimel D
    Harm Reduct J; 2019 Dec; 16(1):72. PubMed ID: 31864356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interest without uptake: A mixed-methods analysis of methadone utilization in Kyrgyz prisons.
    Liberman AR; Bromberg DJ; Litz T; Kurmanalieva A; Galvez S; Rozanova J; Azbel L; Meyer JP; Altice FL
    PLoS One; 2022; 17(10):e0276723. PubMed ID: 36282864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New policy on methadone maintenance treatment in prisons established in Alberta.
    Whitling NJ
    Can HIV AIDS Policy Law Rev; 2003 Dec; 8(3):45-7. PubMed ID: 15108655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A qualitative inquiry into methadone maintenance treatment for opioid-dependent prisoners in Tehran, Iran.
    Zamani S; Farnia M; Tavakoli S; Gholizadeh M; Nazari M; Seddighi AA; Setayesh H; Afshar P; Kihara M
    Int J Drug Policy; 2010 May; 21(3):167-72. PubMed ID: 19395250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The network of Centres for the Prevention and Treatment of Drug Addiction in the Republic of Slovenia.
    Kastelic A; Rihtar TK
    Med Arh; 2001; 55(3):135-9. PubMed ID: 11769426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methadone treatment in British Columbia: bad medicine?
    Alexander BK; Beyerstein BL; MacInnes TM
    CMAJ; 1987 Jan; 136(1):25-8. PubMed ID: 3791087
    [No Abstract]   [Full Text] [Related]  

  • 28. Zoned Out: "NIMBYism", addiction services and municipal governance in British Columbia.
    Bernstein SE; Bennett D
    Int J Drug Policy; 2013 Nov; 24(6):e61-5. PubMed ID: 23680227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methadone maintenance expands inside federal prisons.
    Sibbald B
    CMAJ; 2002 Nov; 167(10):1154. PubMed ID: 12427715
    [No Abstract]   [Full Text] [Related]  

  • 30. Association of Mental Health Services Access and Reincarceration Among Adults Released From Prison in British Columbia, Canada.
    Palis H; Hu K; Rioux W; Korchinski M; Young P; Greiner L; Nicholls T; Slaunwhite A
    JAMA Netw Open; 2022 Dec; 5(12):e2247146. PubMed ID: 36520435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linkage with methadone treatment upon release from incarceration: a promising opportunity.
    Rich JD; McKenzie M; Shield DC; Wolf FA; Key RG; Poshkus M; Clarke J
    J Addict Dis; 2005; 24(3):49-59. PubMed ID: 16186082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attitudes toward methadone maintenance: implications for HIV prevention.
    Zule WA; Desmond DP
    J Psychoactive Drugs; 1998; 30(1):89-97. PubMed ID: 9565212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First Dutch national guidelines--pharmacological care for detained opioid addicts.
    Arends MT; De Haan HA; Van 't Hoff GI
    Int J Prison Health; 2009; 5(4):192-200. PubMed ID: 25757520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug czar seeks new emphasis on methadone treatment.
    AIDS Policy Law; 1997 Oct; 12(20):7. PubMed ID: 11364789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methadone medical maintenance in primary care. An implementation evaluation.
    Merrill JO; Jackson TR; Schulman BA; Saxon AJ; Awan A; Kapitan S; Carney M; Brumback LC; Donovan D
    J Gen Intern Med; 2005 Apr; 20(4):344-9. PubMed ID: 15857492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decisional considerations for methadone uptake in Kyrgyz prisons: The importance of understanding context and providing accurate information.
    Liberman AR; Bromberg DJ; Azbel L; Rozanova J; Madden L; Meyer JP; Altice FL
    Int J Drug Policy; 2021 Aug; 94():103209. PubMed ID: 33838398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medication-assisted therapy for opioid-dependent incarcerated populations in New Mexico: statewide efforts to increase access.
    Trigg BG; Dickman SL
    Subst Abus; 2012; 33(1):76-84. PubMed ID: 22263716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methadone maintenance treatment may improve completion rates and delay opioid relapse for opioid dependent individuals under community corrections supervision.
    Clark CB; Hendricks PS; Lane PS; Trent L; Cropsey KL
    Addict Behav; 2014 Dec; 39(12):1736-40. PubMed ID: 25117851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A qualitative study of diphenhydramine injection in Kyrgyz prisons and implications for harm reduction.
    Meyer JP; Culbert GJ; Azbel L; Bachireddy C; Kurmanalieva A; Rhodes T; Altice FL
    Harm Reduct J; 2020 Oct; 17(1):86. PubMed ID: 33129341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.